The expression of SFRP3 (FRZB) displayed inconsistency between the two databases, with TIMER showing low expression in CRC patients, while GEPIA and its corresponding TCGA database results showed no significant differences between CRC and normal tissues (Fig. 1B, C, and D). This evidence concerns the gene FRZB and colorectal carcinoma.